Notify me when Frazier Life Sciences Management, L.P. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 47 | $3.34B | +$144M | -$130M | +$13.9M | MIRM, NAMS, VRNA, BBIO, ARQT | 13F-HR | 11/14/2025, 12:38 PM |
| Q2 2025 | 49 | $2.5B | +$287M | -$127M | +$160M | MIRM, VRNA, NAMS, BBIO, ARQT | 13F-HR | 8/14/2025, 11:53 AM |
| Q1 2025 | 47 | $2.19B | +$134M | -$225M | -$90.6M | NAMS, MIRM, VRNA, ARQT, BBIO | 13F-HR | 5/15/2025, 04:41 PM |
| Q4 2024 | 50 | $2.41B | +$144M | -$186M | -$42.6M | NAMS, MIRM, VRNA, KRYS, ARQT | 13F-HR | 2/14/2025, 06:44 PM |
| Q3 2024 | 53 | $2.5B | +$288M | -$85.1M | +$203M | MIRM, NAMS, PHAT, KRYS, MBX | 13F-HR | 11/15/2024, 07:41 AM |
| Q2 2024 | 49 | $2.14B | +$258M | -$322M | -$64M | NAMS, MIRM, KRYS, HLVX, PHAT | 13F-HR | 8/15/2024, 12:49 PM |
| Q1 2024 | 50 | $2.37B | +$230M | -$107M | +$123M | NAMS, KRYS, MIRM, HLVX, ALPN | 13F-HR | 5/15/2024, 12:00 PM |
| Q4 2023 | 49 | $1.87B | +$156M | -$85M | +$70.6M | MIRM, HLVX, NAMS, KRYS, BBIO | 13F-HR | 2/14/2024, 01:55 PM |
| Q3 2023 | 51 | $1.5B | +$238M | -$250M | -$11.7M | MIRM, HLVX, KRYS, NAMS, PHAT | 13F-HR | 11/14/2023, 01:40 PM |
| Q2 2023 | 48 | $1.67B | +$153M | -$80.1M | +$72.6M | HLVX, KDNY, PHAT, NAMS, KRYS | 13F-HR | 8/14/2023, 09:48 AM |
| Q1 2023 | 49 | $1.38B | +$109M | -$171M | -$62.1M | HLVX, NAMS, KDNY, ARQT, MIRM | 13F-HR | 5/15/2023, 12:41 PM |
| Q4 2022 | 44 | $1.61B | +$227M | -$39.6M | +$188M | HLVX, IMGO, ARQT, KDNY, NAMS | Restatement | 2/7/2023, 02:30 PM |
| Q3 2022 | 43 | $1.27B | +$201M | -$74.6M | +$127M | HLVX, ARQT, PHAT, KDNY, SNDX | 13F-HR | 11/14/2022, 10:29 AM |
| Q2 2022 | 41 | $1.04B | +$148M | -$179M | -$30.5M | ARQT, HLVX, KRYS, MIRM, KDNY | 13F-HR | 8/10/2022, 03:07 PM |
| Q1 2022 | 42 | $1.17B | $0 | $0 | ARQT, PHAT, MIRM, SRRA, KRYS | 13F-HR | 5/13/2022, 07:15 PM |